Linda Grais

Dr. Linda S.
Grais, MD, is an Independent Non-Executive Director at ICON plc, an Independent Director at Corvus Pharmaceuticals, Inc. and a Director at Research Bridge Partners /Venture Capital/.
She is on the Board of Directors at CollectiveHealth, Inc., ICON plc, Corvus Pharmaceuticals, Inc., Iolyx Therapeutics, Inc, PartnersGlobal, Research Bridge Partners and The J.
David Gladstone Institutes.
Dr. Grais was previously employed as an Independent Director by Deerfield Healthcare Technology Acquisitions Corp., an Independent Director by Zosano Pharma Corp., an Independent Director by PRA Health Sciences, Inc., a President, Chief Executive Officer & Director by OCERA Therapeutics LLC, a Lead Independent Director by ARCA biopharma, Inc., a Managing Member & Partner by Interwest Venture Management Co., an Executive Vice President by SGX Pharmaceuticals, Inc., an Executive Vice President by Structural Genomix, Inc., an Attorney by Wilson Sonsini Goodrich & Rosati PC, and an Assistant Clinical Professor by The University of California, San Francisco.
She received her undergraduate degree from Yale University, a graduate degree from Stanford Law School and a doctorate degree from Yale School of Medicine.